Wentao Zang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Wentao Zang

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

JAMA Pediatrics|June 22, 2026

Considerations Regarding Valved Holding Chamber EfficiencyWentao Zang, Lanlan Li

Nutrition Research (New York, N.Y.)|March 19, 2026

Higher dietary omega-3 polyunsaturated fatty acid intake is associated with reduced all-cause mortality in cancer survivors: A prospective cohort studyWentao Zang, Lanlan Li, Xuelian Zhao, et al.

Nature Communications|December 14, 2025

Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trialHao Wang, Ho Ko, Thomas W Leung, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

JAMA Pediatrics|June 22, 2026

Considerations Regarding Valved Holding Chamber EfficiencyWentao Zang, Lanlan Li

Nutrition Research (New York, N.Y.)|March 19, 2026

Higher dietary omega-3 polyunsaturated fatty acid intake is associated with reduced all-cause mortality in cancer survivors: A prospective cohort studyWentao Zang, Lanlan Li, Xuelian Zhao, et al.

Nature Communications|December 14, 2025

Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trialHao Wang, Ho Ko, Thomas W Leung, et al.

Pageof 1